ResearchSafe

Hexarelin (Hexarelin (Examorelin))

Category: Growth Hormone. Status: Research compound.

The most potent synthetic GHRP with unique cardioprotective properties independent of GH release through cardiac CD36 receptor binding.

How it works

Potent GHSR-1a agonist producing maximal pituitary GH output. Additionally binds cardiac CD36, providing cardioprotection through anti-apoptotic mechanisms independent of GH.

Key facts

  • Molecular weight: 887 Da
  • Half-life: 1-2 hours
  • Bioavailability: High (SubQ)
  • Storage: Lyophilized: -20°C. Reconstituted: 2-8°C.

Dosing overview

  • Typical dose: 100-200 mcg
  • Frequency: 2-3x daily
  • Duration: 4-8 weeks (then break)
  • Route: Subcutaneous

Reported benefits

  • Strongest GH release
  • Cardioprotective effects
  • Recovery acceleration
  • Anti-fibrotic (cardiac)
  • Neuroprotective potential

Possible side effects

  • Cortisol/prolactin increase
  • Rapid desensitization
  • Water retention
  • Flushing

Research

  • Cardioprotective mechanisms of hexarelin via CD36 (2021): Hexarelin reduced infarct size by 40% independent of GH via anti-apoptotic pathways.
  • Hexarelin desensitization kinetics (2019): GH response decreased by 50% after 14 days; full recovery after 4-week washout.

Compare Hexarelin

Community discussions about Hexarelin

Research and educational reference only. Not medical advice.